Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHP Sale Of Cyanamid To BASF Will Re-Open Merger Possibilities

Executive Summary

The sale of American Home Products' agricultural and crop sciences division Cyanamid will give the company a pharmaceutical profile that clears the way for a new round of merger discussions.

You may also be interested in...



Aventis Decision On Ag Business Expected Within 18 Months

Aventis expects to make a decision on carrying forward with its agricultural business component in 2001, Investor Relations Director Arvind Sood said during a July 28 conference call.

Aventis Decision On Ag Business Expected Within 18 Months

Aventis expects to make a decision on carrying forward with its agricultural business component in 2001, Investor Relations Director Arvind Sood said during a July 28 conference call.

Vanguard/Roche Claim To Have Serotonin Obesity Target Without Redux AEs

Vanguard Medica has found a serotonin receptor target that has a role in controlling obesity but is not associated with the cardiovascular side effects of Redux, Vanguard CEO Robert Mansfield told the Chase H&Q Investing in Biotechnology Conference May 10 in London.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035778

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel